‹ Back to screener

ACUTAAS.NS Acutaas Chemicals Ltd.

Healthcare

Price history

2021-09-14 ₹467.50
2026-08-21 ₹3181.50
Change over window +580.53%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 48.7%
Trailing 20-day average 53.5%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 240776 117277 48.71%
2026-08-27 128415 59937 46.67%
2026-08-26 144263 68317 47.36%
2026-08-25 409528 202967 49.56%
2026-08-24 360245 207721 57.66%
2026-08-21 220694 139015 62.99%
2026-08-20 283295 147040 51.90%
2026-08-19 279967 144271 51.53%
2026-08-18 423370 186807 44.12%
2026-08-17 172332 83725 48.58%
2026-08-14 331013 157231 47.50%
2026-08-13 321386 181620 56.51%
2026-08-12 159044 93807 58.98%
2026-08-11 153105 98115 64.08%
2026-08-10 196883 133523 67.82%
2026-08-07 187550 109853 58.57%
2026-08-06 107779 60434 56.07%
2026-08-05 223117 111505 49.98%
2026-08-04 327508 164457 50.21%
2026-08-03 479397 244868 51.08%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers ACUTAAS.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
10 Mar 2026 Vijay Gosar Employees/Designated Employees Sell Market Sale 500 1072131 0.00% XBRL
20 Feb 2026 MEHUL MANSUKHBHAI KOLADIA Employees/Designated Employees Sell Market Sale 20000 42204200 0.40% XBRL
30 Dec 2025 Bhavesh Mansukhbhai Kotadiya Employees/Designated Employees Buy Market Purchase 2100 3511914 0.00% XBRL
20 May 2025 Chetankumar Chhaganlal Vaghasia Promoters Sell Market Sale 1348921 1504046915 14.97% XBRL
20 May 2025 NARESHKUMAR RAMJIBHAI PATEL Promoters Sell Market Sale 1348921 1504046915 17.69% XBRL
06 Jan 2025 RAM MOHAN LOKHANDE Director Buy ESOP 2000 200000 0.00% XBRL
06 Jan 2025 RAM MOHAN LOKHANDE Director Sell Market Sale 400 852000 0.00% XBRL
13 Nov 2024 Chetankumar Chhaganlal Vaghasia Promoters Buy Gift 340500 0 16.62% XBRL
13 Nov 2024 Chhagan Ramjibhai Vaghasia Promoter Group Sell Gift 340500 0 0.00% XBRL
08 Nov 2024 Bhanuben Chhaganlal Vaghasia Promoter Group Sell Gift 342000 0 N/A XBRL
08 Nov 2024 CHETANKUMAR CHHAGANLAL VAGHASIA Promoters Buy Gift 342000 0 15.79% XBRL
05 Nov 2024 Sheetalben N. Patel Promoters Sell Gift 3637500 0 0.00% XBRL
05 Nov 2024 CHETANKUMAR CHHAGANLAL VAGHASIA Promoters Buy Gift 2937500 0 14.95% XBRL
05 Nov 2024 NARESHKUMAR RAMJIBHAI PATEL Promoters Buy Gift 3637500 0 19.34% XBRL
05 Nov 2024 Parulben Vaghasia Promoters Sell Gift 2937500 0 0.00% XBRL
17 Sep 2024 MEHUL MANSUKHBHAI KOLADIA Employees/Designated Employees Sell Market Sale 25000 38510310 0.43% XBRL
28 Dec 2023 CHETANKUMAR CHHAGANLAL VAGHASIA Promoters Buy Market Purchase 86000 100039500 8.63% XBRL
28 Dec 2023 NARESHKUMAR RAMJIBHAI PATEL Promoters Buy Off Market 274914 319999896 11.60% XBRL
14 Sep 2022 Parulben Vaghasia Promoters Sell Market Sale 300000 311175000 8.06% XBRL
14 Sep 2022 Sheetalben N. Patel Promoters Sell Market Sale 300000 311175000 9.98% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers ACUTAAS.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹3169.00 INR (live) · fetched 2026-08-23 21:32 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Ratios

P/E
72.83
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹3,169.00 / (₹3,562,553,000 / 81,871,200 shares) = ₹3,169.00 / ₹43.51 EPS
FY2025-26 · Annual filing
ROE
21.54%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹3,562,553,000 / ₹16,535,610,000 = 21.54%
FY2025-26 · Annual filing
Debt/Equity
0.02
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹264,908,000 / ₹16,535,610,000 = 0.02
FY2025-26 · Annual filing
Current Ratio
3.82
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹8,812,697,000 / ₹2,308,140,000 = 3.82
FY2025-26 · Annual filing
ROCE
28.93%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹4,859,938,000 / (₹16,535,610,000 + ₹264,908,000) = 28.93%
FY2025-26 · Annual filing
Dividend Yield
0.05%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹122,803,000 / 81,871,200 shares) / ₹3,169.00 = ₹1.50 / ₹3,169.00
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 29.5%
Net Profit (3y) N/A
Revenue (5y, 3.0y actual) 29.5%
Net Profit (5y) N/A
Revenue (10y, 3.0y actual) 29.5%
Net Profit (10y) N/A

Operating Margin Trend

Expanding

FY2022-23 18.6%
FY2023-24 16.7%
FY2024-25 22.1%
FY2025-26 36.3%

ROCE Trajectory

FY2022-23 19.2%
FY2023-24 13.3%
FY2024-25 16.7%
FY2025-26 28.0%

Earnings Quality

Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.

Sector-Relative Percentile (Healthcare)

ROE 91th
ROCE 93th
Debt/Equity 72th
P/E 28th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹224.96 Cr. ₹176.67 Cr. ₹246.73 Cr. ₹274.99 Cr. ₹308.48 Cr. ₹207.24 Cr. ₹306.20 Cr. ₹393.18 Cr. ₹432.75 Cr. ₹329.67 Cr. RevenueFromOperations
Net Profit ₹25.15 Cr. incl. minority ₹25.68 Cr. ₹13.95 Cr. incl. minority ₹14.69 Cr. ₹37.33 Cr. incl. minority ₹37.57 Cr. ₹44.95 Cr. incl. minority ₹45.45 Cr. ₹62.48 Cr. incl. minority ₹62.72 Cr. ₹44.29 Cr. incl. minority ₹44.01 Cr. ₹72.24 Cr. incl. minority ₹71.86 Cr. ₹107.96 Cr. incl. minority ₹106.22 Cr. ₹131.76 Cr. incl. minority ₹134.28 Cr. ₹74.26 Cr. incl. minority ₹74.99 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers ACUTAAS.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent3562553000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital81871200.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets8812697000.0
CurrentLiabilities2308140000.0
EquityAttributableToOwnersOfParent16535610000.0
BorrowingsCurrent + BorrowingsNoncurrent264908000.0

My notes